211 related articles for article (PubMed ID: 30848212)
1. Synthesis, Characterization, Quantum-Chemical Calculations and Cytotoxic Activity of 1,8-Naphthalimide Derivatives with Non-Protein Amino Acids.
Marinov MN; Naydenova ED; Momekov GT; Prodanova RY; Markova NV; Voynikov YT; Stoyanov NM
Anticancer Agents Med Chem; 2019; 19(10):1276-1284. PubMed ID: 30848212
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
3. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.
Van Quaquebeke E; Mahieu T; Dumont P; Dewelle J; Ribaucour F; Simon G; Sauvage S; Gaussin JF; Tuti J; El Yazidi M; Van Vynckt F; Mijatovic T; Lefranc F; Darro F; Kiss R
J Med Chem; 2007 Aug; 50(17):4122-34. PubMed ID: 17658777
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and in vitro cytotoxicity of naphthalimide polyamine conjugates as antitumor agents].
Mei ZH; Tian ZY; Ma HX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2009 Jul; 44(7):754-7. PubMed ID: 19806915
[TBL] [Abstract][Full Text] [Related]
5. Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors.
Filosa R; Peduto A; Micco SD; Caprariis Pd; Festa M; Petrella A; Capranico G; Bifulco G
Bioorg Med Chem; 2009 Jan; 17(1):13-24. PubMed ID: 19058969
[TBL] [Abstract][Full Text] [Related]
6. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
7. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
[TBL] [Abstract][Full Text] [Related]
8. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
9. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
Wu A; Xu Y; Qian X
Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives.
Fan YR; Wang BJ; Jia DG; Yang XB; Huang Y
J Inorg Biochem; 2021 Jun; 219():111425. PubMed ID: 33831713
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.
Xie L; Xu Y; Wang F; Liu J; Qian X; Cui J
Bioorg Med Chem; 2009 Jan; 17(2):804-10. PubMed ID: 19070496
[TBL] [Abstract][Full Text] [Related]
13. Tuning of Aggregation Enhanced Emission and Solid State Emission from 1,8-Naphthalimide Derivatives: Nanoaggregates, Spectra, and DFT Calculations.
Srivastava AK; Singh A; Mishra L
J Phys Chem A; 2016 Jul; 120(26):4490-504. PubMed ID: 27294534
[TBL] [Abstract][Full Text] [Related]
14. A New Synthesis of Poly Heterocyclic Compounds Containing [1,2,4]triazolo and [1,2,3,4]tetrazolo Moieties and their DFT Study as Expected Anti-cancer Reagents.
Abdelrehim EM; El-Sayed DS
Curr Org Synth; 2020; 17(3):211-223. PubMed ID: 32101129
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.
Rykowski S; Gurda-Woźna D; Orlicka-Płocka M; Fedoruk-Wyszomirska A; Giel-Pietraszuk M; Wyszko E; Kowalczyk A; Stączek P; Bak A; Kiliszek A; Rypniewski W; Olejniczak AB
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803403
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents.
Verma M; Luxami V; Paul K
Eur J Med Chem; 2013 Oct; 68():352-60. PubMed ID: 23994328
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability.
Nekvinda J; Różycka D; Rykowski S; Wyszko E; Fedoruk-Wyszomirska A; Gurda D; Orlicka-Płocka M; Giel-Pietraszuk M; Kiliszek A; Rypniewski W; Bachorz R; Wojcieszak J; Grüner B; Olejniczak AB
Bioorg Chem; 2020 Jan; 94():103432. PubMed ID: 31776032
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of naphthalimide derivatives with potential anticancer activity, their comparative ds- and G-quadruplex-DNA binding studies and related biological activities.
Yildiz U; Kandemir I; Cömert F; Akkoç S; Coban B
Mol Biol Rep; 2020 Mar; 47(3):1563-1572. PubMed ID: 32095985
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of LOX inhibitory activity of 2-(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-phenylacetamide derivatives.
Mohammadi-Farani A; Haqiqi A; Navid SJ; Aliabadi A
Res Pharm Sci; 2016 Jul; 11(4):265-73. PubMed ID: 27651806
[TBL] [Abstract][Full Text] [Related]
20. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
Tan S; Yin H; Chen Z; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
